CN Stock MarketDetailed Quotes

300765 CSPC Innovation Pharmaceutical

Watchlist
  • 32.01
  • -0.81-2.47%
Market Closed May 17 15:00 CST
44.96BMarket Cap63.76P/E (TTM)

CSPC Innovation Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-27.08%524.07M
-4.75%2.5B
0.46%1.9B
5.47%1.31B
32.84%718.72M
42.00%2.63B
80.54%1.89B
75.53%1.24B
51.49%541.03M
40.40%1.85B
Operating revenue
-27.08%524.07M
-4.75%2.5B
0.46%1.9B
5.47%1.31B
32.84%718.72M
42.00%2.63B
80.54%1.89B
75.53%1.24B
51.49%541.03M
40.40%1.85B
Other operating revenue
----
-7.05%51.35M
----
-22.13%24.71M
----
-8.14%55.25M
----
20.31%31.73M
----
113.24%60.14M
Total operating cost
-24.61%459.22M
-7.92%1.64B
-4.00%1.23B
0.97%851.32M
57.71%609.16M
28.31%1.79B
68.49%1.28B
64.30%843.13M
47.22%386.26M
38.71%1.39B
Operating cost
-23.96%279.3M
-8.31%1.37B
-5.83%1.01B
0.72%706.85M
23.21%367.33M
43.25%1.49B
108.58%1.08B
109.63%701.82M
99.49%298.13M
78.23%1.04B
Operating tax surcharges
-5.03%8.85M
40.05%28.75M
55.21%22.27M
70.79%15.31M
163.71%9.32M
29.92%20.53M
47.30%14.35M
20.70%8.96M
-22.58%3.54M
-15.33%15.8M
Operating expense
-21.44%53.04M
-15.97%205.23M
-8.40%169.92M
-11.34%108.24M
-1.97%67.51M
-8.11%244.25M
-13.22%185.5M
-20.97%122.08M
-30.17%68.87M
-18.97%265.81M
Administration expense
30.91%23.71M
24.54%86.57M
16.70%54.33M
44.95%39.63M
46.73%18.11M
16.92%69.52M
60.91%46.56M
31.95%27.34M
16.98%12.34M
27.12%59.45M
Financial expense
-356.32%-16.15M
-4.61%-90.78M
7.81%-62.54M
-32.82%-41.02M
251.75%6.3M
-401.59%-86.78M
-251.52%-67.84M
-169.47%-30.88M
-28.35%-4.15M
-250.62%-17.3M
-Interest expense (Financial expense)
-91.92%17.71K
62.19%355.57K
-31.08%490.54K
-40.35%365.5K
2,297.12%219.23K
-92.26%219.23K
--711.71K
1,720.60%612.69K
--9.15K
--2.83M
-Interest Income (Financial expense)
56.61%-14.21M
-101.24%-65.9M
-110.38%-42.08M
-95.14%-26.97M
-369.57%-32.75M
-18.40%-32.75M
2.72%-20M
-20.57%-13.82M
-156.13%-6.97M
-221.85%-27.66M
Research and development
-21.42%110.48M
0.52%46.54M
21.86%33.67M
61.53%22.31M
1,767.95%140.59M
74.71%46.3M
132.06%27.63M
91.76%13.81M
211.93%7.53M
88.67%26.5M
Credit Impairment Loss
-1,424.00%-5.22M
162.20%4.86M
123.89%1.83M
133.85%2.08M
87.47%-342.21K
-30.32%-7.82M
-136.25%-7.67M
-74.45%-6.13M
-24.92%-2.73M
-526.06%-6M
Asset Impairment Loss
----
----
----
----
----
----
----
----
----
---4.35M
Other net revenue
-620.97%-8.69M
132.15%33.62M
490.75%9.52M
621.09%8.12M
265.94%1.67M
-50.38%14.48M
-85.87%1.61M
-120.66%-1.56M
-114.44%-1.01M
-36.29%29.19M
Fair value change income
----
----
----
----
----
----
-41.39%1.28M
-66.56%778.14K
----
84.94%3.59M
Invest income
-554.56%-4.61M
-25.21%12.58M
-64.97%1.81M
-52.01%947.48K
-151.09%-704.63K
-5.05%16.82M
-33.50%5.17M
-65.15%1.97M
-49.78%1.38M
-30.32%17.72M
-Including: Investment income associates
----
22.10%12.58M
117.17%1.81M
737.19%947.48K
----
40.92%10.3M
346.26%834.49K
-179.64%-148.7K
23.88%-743.86K
66.57%7.31M
Asset deal income
----
----
----
----
----
--117.54K
----
----
----
----
Other revenue
-58.09%1.14M
201.67%16.18M
108.00%5.88M
179.64%5.09M
681.64%2.71M
-70.57%5.36M
-39.69%2.83M
-40.51%1.82M
-85.93%347.33K
6.97%18.22M
Operating profit
-49.51%56.16M
4.18%891.35M
11.06%681.22M
17.47%466.41M
-27.67%111.22M
75.55%855.59M
104.80%613.35M
96.74%397.04M
51.14%153.77M
35.37%487.36M
Add:Non operating Income
-12.79%657.86K
16.04%2.89M
-4.24%6.43M
58.75%3.43M
21.53%754.32K
183.72%2.49M
614.34%6.71M
562.54%2.16M
104.58%620.67K
-86.68%878.94K
Less:Non operating expense
--29.32K
-63.44%2.45M
-63.26%2.24M
-95.14%269.53K
----
-34.56%6.71M
255.14%6.09M
246.11%5.55M
540.73%3.67M
631.68%10.25M
Total profit
-49.29%56.78M
4.75%891.79M
11.63%685.41M
19.29%469.57M
-25.70%111.98M
78.11%851.37M
105.54%613.97M
96.31%393.65M
48.54%150.72M
30.88%477.99M
Less:Income tax cost
-19.53%26.82M
9.39%136.47M
6.01%101.9M
11.64%68.77M
22.46%33.33M
46.28%124.76M
76.56%96.13M
64.90%61.6M
51.72%27.22M
30.20%85.29M
Net profit
-61.90%29.96M
3.95%755.32M
12.68%583.5M
20.70%400.8M
-36.32%78.65M
85.03%726.61M
112.00%517.85M
103.50%332.05M
47.86%123.5M
31.03%392.7M
Net profit from continuing operation
-61.90%29.96M
3.95%755.32M
----
20.70%400.8M
-36.32%78.65M
85.03%726.61M
----
103.50%332.05M
47.86%123.5M
31.03%392.7M
Less:Minority Profit
3.07%-49.1M
-171.81%-239.7K
-91.25%28.06K
-10.40%179.92K
-286,426.55%-50.66M
163.23%333.78K
277.06%320.6K
167.36%200.8K
94.71%-17.68K
-327.24%-527.89K
Net profit of parent company owners
-38.86%79.06M
4.03%755.56M
12.74%583.48M
20.72%400.62M
4.68%129.3M
84.70%726.28M
111.71%517.53M
103.00%331.85M
47.29%123.52M
31.15%393.23M
Earning per share
Basic earning per share
-40.44%0.0676
0.21%0.6533
-3.80%0.5066
3.85%0.3507
-43.11%0.1135
2.61%0.6519
17.62%0.5266
12.94%0.3377
29.88%0.1995
15.72%0.6353
Diluted earning per share
-40.44%0.0676
0.21%0.6533
-3.80%0.5066
3.85%0.3507
-43.11%0.1135
2.61%0.6519
17.62%0.5266
12.94%0.3377
29.88%0.1995
15.72%0.6353
Other composite income
-212.69%-372.43K
-34.15%1.27M
186.59%977.86K
277.73%1.69M
-134.91%-119.11K
273.95%1.92M
173.78%341.2K
222.88%448.1K
249.19%341.2K
-794.13%-1.1M
Other composite income of parent company owners
-212.69%-372.43K
-34.15%1.27M
186.59%977.86K
277.73%1.69M
-134.91%-119.11K
273.95%1.92M
173.78%341.2K
222.88%448.1K
249.19%341.2K
-794.13%-1.1M
Total composite income
-62.32%29.59M
3.85%756.58M
12.79%584.48M
21.05%402.49M
-36.59%78.53M
86.04%728.53M
112.54%518.19M
104.23%332.5M
48.67%123.84M
30.71%391.6M
Total composite income of parent company owners
-39.09%78.69M
3.93%756.82M
12.86%584.45M
21.07%402.31M
4.30%129.18M
85.71%728.2M
112.25%517.87M
103.73%332.3M
48.10%123.86M
30.83%392.12M
Total composite income of minority owners
3.07%-49.1M
-171.81%-239.7K
-91.25%28.06K
-10.40%179.92K
-286,426.55%-50.66M
163.23%333.78K
277.06%320.6K
167.36%200.8K
94.71%-17.68K
-327.24%-527.89K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -27.08%524.07M-4.75%2.5B0.46%1.9B5.47%1.31B32.84%718.72M42.00%2.63B80.54%1.89B75.53%1.24B51.49%541.03M40.40%1.85B
Operating revenue -27.08%524.07M-4.75%2.5B0.46%1.9B5.47%1.31B32.84%718.72M42.00%2.63B80.54%1.89B75.53%1.24B51.49%541.03M40.40%1.85B
Other operating revenue -----7.05%51.35M-----22.13%24.71M-----8.14%55.25M----20.31%31.73M----113.24%60.14M
Total operating cost -24.61%459.22M-7.92%1.64B-4.00%1.23B0.97%851.32M57.71%609.16M28.31%1.79B68.49%1.28B64.30%843.13M47.22%386.26M38.71%1.39B
Operating cost -23.96%279.3M-8.31%1.37B-5.83%1.01B0.72%706.85M23.21%367.33M43.25%1.49B108.58%1.08B109.63%701.82M99.49%298.13M78.23%1.04B
Operating tax surcharges -5.03%8.85M40.05%28.75M55.21%22.27M70.79%15.31M163.71%9.32M29.92%20.53M47.30%14.35M20.70%8.96M-22.58%3.54M-15.33%15.8M
Operating expense -21.44%53.04M-15.97%205.23M-8.40%169.92M-11.34%108.24M-1.97%67.51M-8.11%244.25M-13.22%185.5M-20.97%122.08M-30.17%68.87M-18.97%265.81M
Administration expense 30.91%23.71M24.54%86.57M16.70%54.33M44.95%39.63M46.73%18.11M16.92%69.52M60.91%46.56M31.95%27.34M16.98%12.34M27.12%59.45M
Financial expense -356.32%-16.15M-4.61%-90.78M7.81%-62.54M-32.82%-41.02M251.75%6.3M-401.59%-86.78M-251.52%-67.84M-169.47%-30.88M-28.35%-4.15M-250.62%-17.3M
-Interest expense (Financial expense) -91.92%17.71K62.19%355.57K-31.08%490.54K-40.35%365.5K2,297.12%219.23K-92.26%219.23K--711.71K1,720.60%612.69K--9.15K--2.83M
-Interest Income (Financial expense) 56.61%-14.21M-101.24%-65.9M-110.38%-42.08M-95.14%-26.97M-369.57%-32.75M-18.40%-32.75M2.72%-20M-20.57%-13.82M-156.13%-6.97M-221.85%-27.66M
Research and development -21.42%110.48M0.52%46.54M21.86%33.67M61.53%22.31M1,767.95%140.59M74.71%46.3M132.06%27.63M91.76%13.81M211.93%7.53M88.67%26.5M
Credit Impairment Loss -1,424.00%-5.22M162.20%4.86M123.89%1.83M133.85%2.08M87.47%-342.21K-30.32%-7.82M-136.25%-7.67M-74.45%-6.13M-24.92%-2.73M-526.06%-6M
Asset Impairment Loss ---------------------------------------4.35M
Other net revenue -620.97%-8.69M132.15%33.62M490.75%9.52M621.09%8.12M265.94%1.67M-50.38%14.48M-85.87%1.61M-120.66%-1.56M-114.44%-1.01M-36.29%29.19M
Fair value change income -------------------------41.39%1.28M-66.56%778.14K----84.94%3.59M
Invest income -554.56%-4.61M-25.21%12.58M-64.97%1.81M-52.01%947.48K-151.09%-704.63K-5.05%16.82M-33.50%5.17M-65.15%1.97M-49.78%1.38M-30.32%17.72M
-Including: Investment income associates ----22.10%12.58M117.17%1.81M737.19%947.48K----40.92%10.3M346.26%834.49K-179.64%-148.7K23.88%-743.86K66.57%7.31M
Asset deal income ----------------------117.54K----------------
Other revenue -58.09%1.14M201.67%16.18M108.00%5.88M179.64%5.09M681.64%2.71M-70.57%5.36M-39.69%2.83M-40.51%1.82M-85.93%347.33K6.97%18.22M
Operating profit -49.51%56.16M4.18%891.35M11.06%681.22M17.47%466.41M-27.67%111.22M75.55%855.59M104.80%613.35M96.74%397.04M51.14%153.77M35.37%487.36M
Add:Non operating Income -12.79%657.86K16.04%2.89M-4.24%6.43M58.75%3.43M21.53%754.32K183.72%2.49M614.34%6.71M562.54%2.16M104.58%620.67K-86.68%878.94K
Less:Non operating expense --29.32K-63.44%2.45M-63.26%2.24M-95.14%269.53K-----34.56%6.71M255.14%6.09M246.11%5.55M540.73%3.67M631.68%10.25M
Total profit -49.29%56.78M4.75%891.79M11.63%685.41M19.29%469.57M-25.70%111.98M78.11%851.37M105.54%613.97M96.31%393.65M48.54%150.72M30.88%477.99M
Less:Income tax cost -19.53%26.82M9.39%136.47M6.01%101.9M11.64%68.77M22.46%33.33M46.28%124.76M76.56%96.13M64.90%61.6M51.72%27.22M30.20%85.29M
Net profit -61.90%29.96M3.95%755.32M12.68%583.5M20.70%400.8M-36.32%78.65M85.03%726.61M112.00%517.85M103.50%332.05M47.86%123.5M31.03%392.7M
Net profit from continuing operation -61.90%29.96M3.95%755.32M----20.70%400.8M-36.32%78.65M85.03%726.61M----103.50%332.05M47.86%123.5M31.03%392.7M
Less:Minority Profit 3.07%-49.1M-171.81%-239.7K-91.25%28.06K-10.40%179.92K-286,426.55%-50.66M163.23%333.78K277.06%320.6K167.36%200.8K94.71%-17.68K-327.24%-527.89K
Net profit of parent company owners -38.86%79.06M4.03%755.56M12.74%583.48M20.72%400.62M4.68%129.3M84.70%726.28M111.71%517.53M103.00%331.85M47.29%123.52M31.15%393.23M
Earning per share
Basic earning per share -40.44%0.06760.21%0.6533-3.80%0.50663.85%0.3507-43.11%0.11352.61%0.651917.62%0.526612.94%0.337729.88%0.199515.72%0.6353
Diluted earning per share -40.44%0.06760.21%0.6533-3.80%0.50663.85%0.3507-43.11%0.11352.61%0.651917.62%0.526612.94%0.337729.88%0.199515.72%0.6353
Other composite income -212.69%-372.43K-34.15%1.27M186.59%977.86K277.73%1.69M-134.91%-119.11K273.95%1.92M173.78%341.2K222.88%448.1K249.19%341.2K-794.13%-1.1M
Other composite income of parent company owners -212.69%-372.43K-34.15%1.27M186.59%977.86K277.73%1.69M-134.91%-119.11K273.95%1.92M173.78%341.2K222.88%448.1K249.19%341.2K-794.13%-1.1M
Total composite income -62.32%29.59M3.85%756.58M12.79%584.48M21.05%402.49M-36.59%78.53M86.04%728.53M112.54%518.19M104.23%332.5M48.67%123.84M30.71%391.6M
Total composite income of parent company owners -39.09%78.69M3.93%756.82M12.86%584.45M21.07%402.31M4.30%129.18M85.71%728.2M112.25%517.87M103.73%332.3M48.10%123.86M30.83%392.12M
Total composite income of minority owners 3.07%-49.1M-171.81%-239.7K-91.25%28.06K-10.40%179.92K-286,426.55%-50.66M163.23%333.78K277.06%320.6K167.36%200.8K94.71%-17.68K-327.24%-527.89K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg